- Did you mean
- comparable
Search results - 6 results
Hepatitis C virus prevalence in Belgium
0.02% (95% CI 0.00–0.07%). The results show a much lower HCV seroprevalence compared to previous studies. Health Topics: Hepatitis A, B, C, D en E Hepatitis A, B, C, D and E Hépatites A, B, C, D et ...
Hepatitis C virus prevalence in Belgium
0.02% (95% CI 0.00–0.07%). The results show a much lower HCV seroprevalence compared to previous studies. Health Topics: Hepatitis A, B, C, D and E Hépatites A, B, C, D et E Hepatitis A, B, C, D en ...
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
comparable to many surrounding countries. These adjusted prevalences can help estimate the cost of reimbursement of DAA s and invite Belgian policy makers to accelerate the scaling up of reimbursement, giving ...
Subtype-specific differences in the risk of hospitalisation among patients infected with hepatitis E virus genotype 3 in Belgium, 2010-2018.
established to date. Here, we report that patients infected with HEV-3c were at lower risk of hospitalisation, compared to those infected with HEV-3f, the other main subtype circulating in Belgium. Health ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
59.1% of those with an unknown injecting status were tested for HCV, compared to 86.5% of the patients who had recently injected and 84.5% of those who had ever injected. 36.8% of the people who had ...
A rat model for hepatitis E virus.
chimeric replicon replicated with comparable efficiency as the wild-type construct, confirming that LA- B350 strain is amenable to humanization (replacement of certain sequences or motifs by their ...